Altimmune to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on February 27, 2025
Altimmune (Nasdaq: ALT) has announced it will release its fourth quarter and full year 2024 financial results on Thursday, February 27, 2025. The clinical-stage biopharmaceutical company will host a conference call at 8:30 am E.T. on the same day, during which management will discuss financial results and provide a business update.
The conference call will be accessible through a webcast on Altimmune's Investor Relations website. Interested participants can register online to receive dial-in numbers and a unique PIN for call access. A replay of the call will be available on the company's Investor Relations website for up to three months following the event.
Altimmune (Nasdaq: ALT) ha annunciato che rilascerà i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 giovedì 27 febbraio 2025. La società biofarmaceutica in fase clinica ospiterà una conferenza telefonica alle 8:30 ora orientale dello stesso giorno, durante la quale la direzione discuterà i risultati finanziari e fornirà un aggiornamento sull'andamento aziendale.
La conferenza telefonica sarà accessibile tramite un webcast sul sito web delle Relazioni con gli Investitori di Altimmune. I partecipanti interessati possono registrarsi online per ricevere i numeri di accesso e un PIN unico per partecipare alla chiamata. Una registrazione della chiamata sarà disponibile sul sito web delle Relazioni con gli Investitori della società per un massimo di tre mesi dopo l'evento.
Altimmune (Nasdaq: ALT) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 el jueves 27 de febrero de 2025. La compañía biofarmacéutica en etapa clínica llevará a cabo una conferencia telefónica a las 8:30 a.m. hora del este el mismo día, durante la cual la dirección discutirá los resultados financieros y proporcionará una actualización del negocio.
La conferencia telefónica será accesible a través de una transmisión web en el sitio web de Relaciones con Inversores de Altimmune. Los participantes interesados pueden registrarse en línea para recibir los números de acceso y un PIN único para acceder a la llamada. Una repetición de la llamada estará disponible en el sitio web de Relaciones con Inversores de la compañía durante un máximo de tres meses después del evento.
Altimmune (Nasdaq: ALT)은 2024년 4분기 및 전체 연도 재무 결과를 2025년 2월 27일 목요일에 발표할 것이라고 발표했습니다. 임상 단계의 생명공학 회사는 같은 날 동부 표준시로 오전 8시 30분에 컨퍼런스 콜을 개최하며, 이 자리에서 경영진이 재무 결과를 논의하고 사업 업데이트를 제공할 예정입니다.
컨퍼런스 콜은 Altimmune의 투자자 관계 웹사이트를 통해 웹캐스트로 접근할 수 있습니다. 관심 있는 참가자는 온라인으로 등록하여 전화 접속을 위한 다이얼인 번호와 고유한 PIN을 받을 수 있습니다. 통화의 재생은 이벤트 후 최대 3개월 동안 회사의 투자자 관계 웹사이트에서 제공됩니다.
Altimmune (Nasdaq: ALT) a annoncé qu'il publiera ses résultats financiers du quatrième trimestre et de l'année complète 2024 le jeudi 27 février 2025. La société biopharmaceutique en phase clinique organisera une conférence téléphonique à 8h30, heure de l'Est, le même jour, au cours de laquelle la direction discutera des résultats financiers et fournira une mise à jour sur les activités de l'entreprise.
La conférence téléphonique sera accessible via un webinaire sur le site Web des Relations avec les Investisseurs d'Altimmune. Les participants intéressés peuvent s'inscrire en ligne pour recevoir les numéros de connexion et un code PIN unique pour accéder à l'appel. Un enregistrement de l'appel sera disponible sur le site Web des Relations avec les Investisseurs de la société pendant une période maximale de trois mois après l'événement.
Altimmune (Nasdaq: ALT) hat bekannt gegeben, dass es seine Finanzergebnisse für das vierte Quartal und das gesamte Jahr 2024 am Donnerstag, den 27. Februar 2025, veröffentlichen wird. Das biopharmazeutische Unternehmen in klinischer Phase wird am selben Tag um 8:30 Uhr EST eine Telefonkonferenz abhalten, in der das Management die Finanzergebnisse besprechen und ein Update zum Geschäft geben wird.
Die Telefonkonferenz wird über ein Webcast auf der Investor-Relations-Website von Altimmune zugänglich sein. Interessierte Teilnehmer können sich online registrieren, um die Einwahlnummern und eine einzigartige PIN für den Zugang zur Konferenz zu erhalten. Eine Aufzeichnung der Konferenz wird bis zu drei Monate nach der Veranstaltung auf der Investor-Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
GAITHERSBURG, Md., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its fourth quarter and full year 2024 financial results on Thursday, February 27, 2025.
Altimmune management will host a conference call at 8:30 am E.T. on February 27 to discuss financial results and provide a business update. The conference call will be webcast live on Altimmune’s Investor Relations website at https://ir.altimmune.com/investors.
Participants who would like to join the call may register here to receive the dial-in numbers and unique PIN to access the call. Shortly after the call, a replay will be available on the Investor Relations website for up to three months.
About Altimmune
Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity and MASH. For more information, please visit www.altimmune.com.
Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter
Company Contact:
Greg Weaver
Chief Financial Officer
Phone: 240-654-1450
ir@altimmune.com
Investor Contact:
Lee Roth
Burns McClellan
Phone: 646-382-3403
lroth@burnsmc.com
Media Contact:
Danielle Cantey
Inizio Evoke, Biotech
Phone: 619-826-4657
Danielle.cantey@inizioevoke.com
This press release was published by a CLEAR® Verified individual.
FAQ
When will Altimmune (ALT) report Q4 and full year 2024 earnings?
What time is Altimmune's (ALT) Q4 2024 earnings call?
How can investors access Altimmune's (ALT) Q4 2024 earnings call?
How long will Altimmune's (ALT) Q4 2024 earnings call replay be available?
